Andlauer Healthcare Group Inc.
ANDHF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $157 | $166 | $168 | $160 |
| % Growth | -5.7% | -1.3% | 5.4% | – |
| Cost of Goods Sold | $121 | $129 | $129 | $122 |
| Gross Profit | $36 | $37 | $40 | $37 |
| % Margin | 22.9% | 22.1% | 23.5% | 23.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $17 | $15 | $13 | $13 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $17 | $15 | $13 | $13 |
| Operating Income | $19 | $22 | $27 | $24 |
| % Margin | 12.1% | 13% | 15.9% | 14.9% |
| Other Income/Exp. Net | -$0 | $4 | -$3 | -$2 |
| Pre-Tax Income | $18 | $25 | $24 | $22 |
| Tax Expense | $5 | $5 | $7 | $6 |
| Net Income | $13 | $20 | $18 | $16 |
| % Margin | 8.6% | 12.2% | 10.4% | 10.2% |
| EPS | 0.34 | 0.51 | 0.44 | 0.41 |
| % Growth | -33.3% | 15.9% | 7.3% | – |
| EPS Diluted | 0.34 | 0.51 | 0.44 | 0.41 |
| Weighted Avg Shares Out | 39 | 39 | 39 | 39 |
| Weighted Avg Shares Out Dil | 40 | 40 | 40 | 40 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $2 |
| Depreciation & Amortization | $18 | $18 | $18 | $17 |
| EBITDA | $38 | $45 | $44 | $42 |
| % Margin | 24.5% | 27.3% | 26% | 26.2% |